Transcription of Product Information - Medicines
{{id}} {{{paragraph}}}
Example: biology
Product Information - Medicines
LUCRIN leuprorelin acetate 5mg/mL injection multidose Version 16 09 October 2018 Page 1 of 10 AUSTRALIAN Product Information LUCRIN (LEUPRORELIN ACETATE) 1. NAME OF THE MEDICINE NON-PROPRIETARY NAME Leuprorelin acetate 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 5mL multi-dose vial contains of solution (14 doses). In solution contains 1mg of leuprorelin acetate. For the full list of excipients, see Section List of excipients. 3. PHARMACEUTICAL FORM Clear, sterile solution supplied in clear glass multi-dose vials 4. CLINICAL PARTICULARS Therapeutic Indications Lucrin (leuprorelin acetate) is indicated in the palliative treatment of metastatic or locally extensive prostatic cancer (Stage C and D).
LUCRIN leuprorelin acetate 5mg/mL injection multidose Version 15 24 February 2017 Page 2 of 8 patients. In males, androgens are reduced to castrate levels.
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: